← Back to Clinical Trials
Recruiting Phase 1 NCT02781519
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
Trial Parameters
Condition Cannabis
Sponsor Yale University
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 55 Years
Start Date 2015-06
Completion 2026-06
Interventions
THCPlacebo
Brief Summary
The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.
Eligibility Criteria
Inclusion Criteria: * at least one lifetime exposure to cannabis * good physical and mental health Exclusion Criteria: * cannabis naive individuals * major current or recent stressors * taking estrogen supplements or oral contraceptive pills (for women)